IRIS
SANTINI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 20.899
NA - Nord America 5.210
EU - Europa 2.020
SA - Sud America 1.576
AF - Africa 151
OC - Oceania 71
AN - Antartide 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 29.931
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 14.161
US - Stati Uniti d'America 4.892
CN - Cina 2.794
HK - Hong Kong 2.682
BR - Brasile 1.196
GB - Regno Unito 770
VN - Vietnam 682
IT - Italia 368
DE - Germania 241
AR - Argentina 177
IN - India 172
CA - Canada 167
MX - Messico 105
ID - Indonesia 93
NL - Olanda 87
ZA - Sudafrica 79
FI - Finlandia 75
AU - Australia 65
UA - Ucraina 64
JP - Giappone 61
PL - Polonia 59
EC - Ecuador 58
TR - Turchia 45
ES - Italia 43
FR - Francia 40
RU - Federazione Russa 40
PY - Paraguay 39
CZ - Repubblica Ceca 33
SE - Svezia 33
BD - Bangladesh 32
CO - Colombia 32
CL - Cile 26
PE - Perù 23
CH - Svizzera 18
LT - Lituania 18
BE - Belgio 17
EE - Estonia 17
KR - Corea 15
MA - Marocco 15
EG - Egitto 14
UZ - Uzbekistan 14
SA - Arabia Saudita 13
VE - Venezuela 13
IQ - Iraq 11
AZ - Azerbaigian 10
IL - Israele 10
DO - Repubblica Dominicana 9
PK - Pakistan 9
TW - Taiwan 9
UY - Uruguay 9
AT - Austria 8
PH - Filippine 8
SI - Slovenia 8
KZ - Kazakistan 7
PT - Portogallo 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
HU - Ungheria 6
KG - Kirghizistan 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
AL - Albania 5
BA - Bosnia-Erzegovina 5
GT - Guatemala 5
MD - Moldavia 5
OM - Oman 5
TH - Thailandia 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
CY - Cipro 4
DM - Dominica 4
DZ - Algeria 4
HN - Honduras 4
IE - Irlanda 4
JO - Giordania 4
KH - Cambogia 4
LU - Lussemburgo 4
MY - Malesia 4
NP - Nepal 4
RS - Serbia 4
CR - Costa Rica 3
ET - Etiopia 3
HR - Croazia 3
IR - Iran 3
JM - Giamaica 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
AQ - Antartide 2
BF - Burkina Faso 2
BO - Bolivia 2
BZ - Belize 2
CI - Costa d'Avorio 2
Totale 29.871
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.664
Singapore 1.807
Ashburn 1.415
Hefei 1.389
Boardman 799
London 672
Shanghai 478
Dallas 445
Beijing 437
Ho Chi Minh City 237
Los Angeles 174
San Francisco 164
Hanoi 150
Council Bluffs 139
São Paulo 122
Pune 103
Seattle 102
Toronto 96
Munich 95
Santa Clara 85
New York 74
Washington 66
Rome 63
Warsaw 52
Mexico City 49
Tokyo 49
Rio de Janeiro 45
Amsterdam 44
Turku 40
Brooklyn 39
Johannesburg 37
Montreal 36
Helsinki 35
Melbourne 33
Chicago 32
Haiphong 32
Brno 29
Thái Bình 28
Boston 27
Stockholm 27
Biên Hòa 26
Da Nang 26
Chennai 24
Milan 23
Belo Horizonte 22
Buenos Aires 21
Naples 20
Guayaquil 19
Quito 19
Secaucus 19
Brasília 18
Asunción 17
Phoenix 17
Canberra 16
Lima 16
Sydney 16
West Jordan 16
Ninh Bình 15
Ribeirão Preto 15
Atlanta 14
Campinas 14
Charlotte 14
Tashkent 14
Ankara 13
Manchester 13
Paris 13
Curitiba 12
Hanover 12
Hasselt 12
Jakarta 12
Porto Alegre 12
San Jose 12
St Louis 12
Oklahoma City 11
Salvador 11
Sorocaba 11
Bắc Giang 10
Caxias do Sul 10
Guangzhou 10
Ha Long 10
Haikou 10
Hải Dương 10
Riyadh 10
Viamão 10
Bogotá 9
Boydton 9
Bắc Ninh 9
Denver 9
Goiânia 9
Guarulhos 9
Joinville 9
New Delhi 9
Santo André 9
The Dalles 9
Cairo 8
Camaçari 8
Fortaleza 8
Hortolândia 8
Hyderabad 8
Maceió 8
Totale 13.205
Salva come PNG Salva come JPEG
Nome #
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 234
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 230
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 230
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 223
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 216
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 214
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 213
Designing a broad-spectrum integrative approach for cancer prevention and treatment 213
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 210
Early impairment of food intake in patients newly diagnosed with cancer 208
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 207
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 205
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 203
A key opinion leader interview with Prof D Santini: insight into cancer research. 202
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 202
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 199
Premetastatic niche: ready for new therapeutic interventions? 198
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 198
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 197
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 197
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 197
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 196
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 196
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 196
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer 194
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 192
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 190
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 188
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 188
Prevention of radiotherapy-induced emesis 188
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 187
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 186
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 183
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 180
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 180
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 179
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 176
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 176
Docetaxel induced pericardial effusion 170
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 159
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 144
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 129
A giant sarcoma of the parotid gland: A case report and review of the literature 122
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 119
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 118
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 117
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 113
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 112
Anestesia e malattie non comuni 109
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 109
'Old' and 'new' drugs for the treatment of cancer pain 109
Colorectal carcinomas and PTEN/MMAC1 gene mutations 107
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 105
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome 105
Biological effects of cabozantinib on bone microenvironment 103
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 102
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 102
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 101
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 100
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 100
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 100
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 99
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 98
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 98
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 97
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 97
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 97
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 96
Idiosyncratic reaction after oxaliplatin infusion 96
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 96
[Treatment of stage-I seminoma. Critical review] 96
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 96
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 96
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 96
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 95
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 95
Atypical chronic head and neck pain: don't forget Eagle's syndrome 95
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 95
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 94
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 93
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 92
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 91
Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature 91
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 91
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 90
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 89
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 88
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 85
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 85
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 84
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 82
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 81
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 80
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 78
Classic Kaposi Sarcoma: to treat or not to treat? 72
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 71
Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis 70
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 70
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 69
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 63
Totale 13.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 300.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 300.086
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.008 0 4 5 8 73 10 15 4 42 20 23 804
2022/2023203 18 7 3 13 16 7 18 20 9 3 80 9
2023/20242.295 52 281 95 171 237 1.039 17 154 23 59 75 92
2024/202518.553 334 274 922 147 171 510 314 63 1.954 1.573 5.751 6.540
2025/20268.007 1.870 776 1.374 2.466 701 820 0 0 0 0 0 0
Totale 30.066